Celecoxib: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Celecoxib. Educational only — not medical advice.
Reported adverse reactions
| Reaction | Highest frequency reported* |
|---|---|
| Any event | 72% |
| Gastrointestinal | 36% |
| Infections | 27% |
| Nervous system | 21% |
| Headache | 20.2% |
| General | 18% |
| Skin & subcutaneous | 18% |
| Musculoskeletal | 17% |
| Headache nos | 16% |
| Respiratory | 15% |
| Dyspepsia | 12.8% |
| Hypertension | 12.5% |
| Vomiting nos | 11% |
| Pyrexia | 11% |
| Investigations* | 11% |
| Abdominal pain upper | 10% |
| Upper respiratory infection | 9.9% |
| Diarrhea | 9.3% |
| Abdominal pain | 9% |
| Diarrhea nos | 8% |
*Highest percentage across placebo-controlled trial tables summarized in current labeling.
Labeled uses
Carefully consider the potential benefits and risks of celecoxib and other treatment options before deciding to use celecoxib. Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5) ] 1.1 Osteoarthritis (OA)Celecoxib is indicated for relief of the signs and symptoms of OA [see Clinical Studies (14.1) ] 1.2 Rheumatoid Arthritis (RA)Celecoxib is indicated for relief of the signs and symptoms of RA [see Clinical Studies (14.2) ] 1.3 Juvenile Rheumatoid Arthritis (JRA)Celecoxib is indicated for relief of the signs and symptoms of JRA in patients 2 years and older [see Clinical Studies (14.3) ] 1.4 Ankylosing Spondylitis (AS)Celecoxib is indicated for the relief of signs and symptoms of AS [see Clinical Studies (14.4) ] 1.5 Acute Pain (AP)Celecoxib is indicated for the management of AP in adults [see Clinical Studies (14.5) ] 1.6 Primary Dysmenorrhea (PD)Celecoxib is indicated for the treatment of PD [see Clinical Studies (14.5) ]
Medical disclaimer: Always consult a qualified healthcare professional about any medication.